Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain

J Cereb Blood Flow Metab. 2009 Apr;29(4):715-25. doi: 10.1038/jcbfm.2008.164. Epub 2009 Jan 14.

Abstract

In the ischemic brain, reperfusion with tissue plasminogen activator (tPA) sometimes causes catastrophic hemorrhagic transformation (HT); however, the mechanism remains elusive. Here, we show that the basement membrane, and not the endothelial cells, is vulnerable to ischemic/reperfusion injury with tPA treatment. We treated a spontaneously hypertensive rat model of middle cerebral artery occlusion (MCAO) with vehicle alone, tPA alone, or a free radical scavenger, edaravone, plus tPA. Light and electron microscopic analyses of each microvascular component revealed that the basement membrane disintegrated and became detached from the astrocyte endfeet in tPA-treated animals that showed HT. On the other hand, edaravone prevented the dissociation of the neurovascular unit, dramatically decreased the HT, and improved the neurologic score and survival rate of the tPA-treated rats. These results suggest that the basement membrane that underlies the endothelial cells is a key structure for maintaining the integrity of the neurovascular unit, and a free-radical scavenger can be a viable agent for inhibiting tPA-induced HT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antipyrine / analogs & derivatives
  • Antipyrine / pharmacology
  • Antipyrine / therapeutic use
  • Basement Membrane / pathology*
  • Brain Ischemia / complications*
  • Brain Ischemia / therapy
  • Cerebral Hemorrhage / chemically induced*
  • Edaravone
  • Free Radical Scavengers / therapeutic use
  • Infarction, Middle Cerebral Artery
  • Rats
  • Rats, Inbred SHR
  • Reperfusion
  • Thrombolytic Therapy / adverse effects*
  • Thrombolytic Therapy / methods
  • Tissue Plasminogen Activator / adverse effects*
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Free Radical Scavengers
  • Tissue Plasminogen Activator
  • Edaravone
  • Antipyrine